1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MTIF3 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA C17orf51 CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA ANKRD26 CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA SNTA1 CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA AMFR CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA SGCE CTRPv2 pan-cancer AAC -0.15 0.0002
mRNA GJB2 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA PTPN7 CTRPv2 pan-cancer AAC 0.18 0.0002
mRNA UBQLN2 CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA DENND5B CTRPv2 pan-cancer AAC -0.13 0.0002
Download CSV